Table 2.
Logistic regression analysis
| Stage 2 cystocele | Stage 3 or 4 cystocele | OR (95% CI) | P -value | |||
|---|---|---|---|---|---|---|
| n | n or Mean (% or range) | n | n or Mean (% or range) | |||
| Age (years) | 137 | 55.1 (31–83) | 132 | 61.3 (39–87) | 1.07 (1.04–1.10) | <0.01 |
| BMI (kg/m2) | 119 | 26.0 (18.4–41.9) | 122 | 26.0 (17.5–35.2) | 1.00 (0.93–1.07) | 1.00 |
| Vaginal delivery (n) | 129 | 2.3 (0–4) | 129 | 2.3 (0–9) | 1.05 (0.83–1.34) | 0.67 |
| Assisted delivery (yes/no), n (%) | 129 | 15 (11.6%) | 129 | 16 (12.4%) | 1.08 (0.51–2.28) | 0.85 |
| Family history of POP (yes/no), n (%) | 128 | 51 (39.8%) | 124 | 58 (46.8%) | 1.33 (0.81–2.19) | 0.27 |
| Concurrent rectocele (yes/no), n (%) | 136 | 63 (46.3%) | 132 | 52 (39.4%) | 0.76 (0.47–1.24) | 0.28 |
| Concurrent uterine of vaginal vault prolapse (yes/no), n (%) | 137 | 79 (57.7%) | 132 | 82 (62.1%) | 1.20 (0.74–1.96) | 0.46 |
| Major levator defect (yes/no), n (%) | 133 | 58 (43.6%) | 129 | 61 (47.3%) | 1.16 (0.71–1.89) | 0.55 |
| Hiatus during Valsalva (cm2), mean (range) | 130 | 33.0 (16.8–58.5) | 126 | 33.5 (18.9–67.4) | 1.01 (0.98–1.04) | 0.59 |
OR odds ratio, CI confidence interval, BMI body mass index, POP pelvic organ prolapse